<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03403881</url>
  </required_header>
  <id_info>
    <org_study_id>15-0532</org_study_id>
    <nct_id>NCT03403881</nct_id>
  </id_info>
  <brief_title>Movement for Depression - An RCT Assessing the Effects of Physical Activity Promotion for People With MDD</brief_title>
  <acronym>MOVEDEP</acronym>
  <official_title>Avaliação de Uma intervenção de promoção Atividade física em Pacientes Com depressão Maior em Atendimento Ambulatorial (MOVEDEP): um Ensaio clínico Randomizado</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Clinicas de Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Clinicas de Porto Alegre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized clinical trial that aims to increase physical activity levels in people with
      depression and to evaluate if the increase on PA levels has impact on clinical and biological
      measures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The contacts will be made by face-to-face interviews and telephone calls
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Depressive symptoms (blinded assessment)</measure>
    <time_frame>At the end of the intervention (6 months)</time_frame>
    <description>Hamilton scale for depressive symptoms assessed by a blinded psychiatrist. Clinician-administered semi-structured interview with 17 questions. It is designed to measure the severity of depressive symptoms in patients with a primary depressive illness. Higher scores means higher depressive symptoms. The cutoffs are the following: following severity ranges for the HAMD: no depression (0-7); mild depression (8-16); moderate depression (17-23); and severe depression (≥24). The maximum score is 52.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physical activity - self-report</measure>
    <time_frame>At the end of the intervention (6 months)</time_frame>
    <description>IPAQ</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity levels - objective measure</measure>
    <time_frame>At the end of the intervention (6 months)</time_frame>
    <description>pedometer (only for intervention group)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>At the end of the intervention (6 months)</time_frame>
    <description>WHOQOL-BREF</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depressive symptoms (self-reported)</measure>
    <time_frame>At the end of the intervention (6 months)</time_frame>
    <description>Beck depressive inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Melancholia</measure>
    <time_frame>At the end of the intervention (6 months)</time_frame>
    <description>assessed using the CORE instrument</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>At the end of the intervention (6 months)</time_frame>
    <description>Weight in kilograms</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>Physical activity promotion + TAU</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Physical activity promotion based on:
Pedometers use;
Weekly contact (telephone or face-to-face);
Contact based on a self-determination theory.
TAU:
Treatment as usual, which include medications. Medications were prescribed by psychiatrists not involved in the study participation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Weekly calls with general health content.
TAU:
Treatment as usual, which include medications. Medications were prescribed by psychiatrists not involved in the study participation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Physical activity promotion + TAU</intervention_name>
    <description>Pedometer:
Each patient will receive a pedometer with increasing weekly aims on number of steps during the trial.
The number of steps to be achieved starts on 4.000 and increases progressively until the end of the trial.
Behavioral strategy based on STD theory, and the assessment of barriers and facilitators of each patient.
All patients were receiving treatment as usual</description>
    <arm_group_label>Physical activity promotion + TAU</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Weekly call on general health aspects + treatment as usual</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age: 18 - 65 years;

          -  diagnosis of Major Depressive Disorder (DSM-IV), assessed by a trained psychiatrist;

          -  score 7 or more in the HAM-D;

          -  do not present clinical comorbidities that limit or contra-indicate the practice of
             physical activity;

          -  be starting depression treatment at the Programa de transtorno do humor (PROTHUM) ;

          -  have acess to a computer and have a facebook account;

          -  be able to read and sign the consent term.

        Exclusion Criteria:

          -  present other psychiatric diagnosis such as bipolar disorder, schizophrenia or use of
             alcohol or other drugs;

          -  be not liberated to the practice of physical exercises by the assistant psychiatrist.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcelo B Fleck, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Researcher</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>, PhD</last_name>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Felipe Schuch, PhD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital de Clínicas de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felipe B Schuch, PhD</last_name>
      <phone>+55 51 99927709</phone>
      <email>felipe.schuch@ufrgs.br</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Schuch FB, Vasconcelos-Moreno MP, Borowsky C, Zimmermann AB, Rocha NS, Fleck MP. Exercise and severe major depression: effect on symptom severity and quality of life at discharge in an inpatient cohort. J Psychiatr Res. 2015 Feb;61:25-32. doi: 10.1016/j.jpsychires.2014.11.005. Epub 2014 Nov 21.</citation>
    <PMID>25439084</PMID>
  </reference>
  <reference>
    <citation>Stubbs B, Vancampfort D, Rosenbaum S, Ward PB, Richards J, Ussher M, Schuch FB. Challenges Establishing the Efficacy of Exercise as an Antidepressant Treatment: A Systematic Review and Meta-Analysis of Control Group Responses in Exercise Randomised Controlled Trials. Sports Med. 2016 May;46(5):699-713. doi: 10.1007/s40279-015-0441-5. Review.</citation>
    <PMID>26707338</PMID>
  </reference>
  <reference>
    <citation>Schuch FB, Vancampfort D, Richards J, Rosenbaum S, Ward PB, Stubbs B. Exercise as a treatment for depression: A meta-analysis adjusting for publication bias. J Psychiatr Res. 2016 Jun;77:42-51. doi: 10.1016/j.jpsychires.2016.02.023. Epub 2016 Mar 4. Review.</citation>
    <PMID>26978184</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2017</study_first_submitted>
  <study_first_submitted_qc>January 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 19, 2018</study_first_posted>
  <last_update_submitted>February 5, 2018</last_update_submitted>
  <last_update_submitted_qc>February 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Exercise</keyword>
  <keyword>Physical activity</keyword>
  <keyword>Behavioral change</keyword>
  <keyword>Depression</keyword>
  <keyword>Major Depressive Disorder</keyword>
  <keyword>Health promotion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

